Literature DB >> 6998937

Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung.

C A Perez, K Stanley, P Rubin, S Kramer, L W Brady, J E Marks, R Perez-Tamayo, G S Brown, J P Concannon, M Rotman.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 6998937     DOI： 10.1016/0360-3016(80)90106-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  8 in total

1.  A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer.

Authors:  Jeremy P Harris; Manali I Patel; Billy W Loo; Heather A Wakelee; Maximilian Diehn
Journal:  Lung Cancer       Date:  2017-03-29       Impact factor: 5.705

2.  Radiotherapy and chemotherapy for inoperable non-small cell lung cancer.

Authors:  C Bleasdale; B Jones
Journal:  Postgrad Med J       Date:  1995-07       Impact factor: 2.401

3.  Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. The Ludwig Lung Cancer Study Group.

Authors: 
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

4.  [Lung cancer--hopelessness in inoperability? A 10-year follow-up].

Authors:  N Schwegler
Journal:  Strahlenther Onkol       Date:  1997-07       Impact factor: 3.621

Review 5.  Lung cancer--current concepts and controversies.

Authors:  S B Pett; J A Wernly; B F Akl
Journal:  West J Med       Date:  1986-07

6.  [Results of irradiation of inoperable stage III non-small cell lung cancer with 25Gy in five fractions].

Authors:  S Appold; M Baumann; F Neidt; T Herrmann
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 4.033

7.  Role of multimodality therapy in cIIIA-N2 non-small cell lung cancer: perspective.

Authors:  Hidehito Horinouchi
Journal:  Jpn J Clin Oncol       Date:  2016-10-04       Impact factor: 3.019

Review 8.  A narrative review of toxicity of chemoradiation and immunotherapy for unresectable, locally advanced non-small cell lung cancer.

Authors:  Rahul N Prasad; Terence M Williams
Journal:  Transl Lung Cancer Res       Date:  2020-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.